您的位置: 首页 > 农业专利 > 详情页

SYSTÈME DE RÉGULATION DE L'ANGIOGENÈSE MODIFIÉS ARTIFICIELLEMENT
专利权人:
Seoul National University Hospital;Toolgen Incorporated;Seoul National University R & DB Foundation
发明人:
申请号:
EP17841736.6
公开号:
EP3502261A1
申请日:
2017.08.21
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention relates to artificially engineered angiogenesis-related factors and a use thereof, for angiogenesis regulation. More specifically, the present invention relates to a system that can artificially regulate angiogenesis, including artificially engineered angiogenesis-related factors to regulate angiogenesis and/or a composition capable of artificially engineering angiogenesis-related factors. In specific aspects, the present invention relates to artificially engineered angiogenesis-related factors such as VEGFA, HIF1A, ANGPT2, EPAS1, ANGPTL4, etc. and/or an angiogenesis regulatory system by their expression products thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充